Wire

Jscreen announces the Sixth Annual Jewish Genetic Screening Awareness Week

“Genetic testing is a vital step toward preventing devastating diseases and ensuring healthier generations.”

Illustrative: genetic testing. Credit: JScreen.
Illustrative: genetic testing. Credit: JScreen.

The national nonprofit public-health initiative jscreen, which is dedicated to preventing genetic diseases, announces its sixth annual Jewish Genetic Screening Awareness Week from Feb. 3-8. The educational program aims to raise awareness about the importance of Jewish genetic testing, a critical tool in preventing hereditary diseases that disproportionately affect individuals of Jewish descent.

Jscreen recently changed its name to jscreen.

For Dr. Matthew Goldstein, CEO of jscreen, his involvement with the organization is not just professional—it is deeply personal. In 2021, he and his wife, Myra Sack, experienced the devastating loss of their oldest child and daughter, 2-year-old Havi, to Tay-Sachs disease, a rare genetic disorder that primarily affects infants and young children.

Tay-Sachs is significantly more common among Ashkenazi Jews, where the carrier frequency is 1 in 30 compared to 1 in 300 in the general population. This tragedy inspired Goldstein to become a passionate advocate for genetic screening and education.

“Losing Havi to Tay-Sachs shattered our world. No family should ever have to endure this kind of loss,” said Goldstein. “Our mission at jscreen is to ensure that families are equipped with the tools and knowledge to make informed decisions about their genetic health, so they can avoid similar tragedies.”

The organization provides affordable, at-home genetic testing kits, offering individuals and couples access to critical health information without barriers. It offers two key tests:

  • Reproductive Carrier Screen evaluates hundreds of genetic conditions, including Tay-Sachs, that are common in Jewish and other communities, enabling families to plan for healthy pregnancies.
  • Hereditary Cancer Test identifies genetic mutations linked to cancers such as breast, ovarian and colorectal cancer, allowing for prevention or early diagnosis and treatment.

“Knowledge is power,” Goldstein said. “Genetic testing is a vital step toward preventing devastating diseases and ensuring healthier generations. By raising awareness through initiatives like Jewish Genetic Screening Awareness Week, we hope to empower communities to take proactive steps for their future.”

Visit jscreen.org  to learn more about Jewish genetic testing or to order a testing kit.

About & contact The Publisher
Jscreen is a national nonprofit public health initiative dedicated to preventing genetic diseases. Headquartered in Atlanta at Emory University School of Medicine, the initiative provides convenient at-home access to cutting-edge genetic testing technology, patient education and genetic counseling services. The nonprofit believes that the combination of education, access to premier gene screening technologies and personalized, confidential support are the keys to preventing these devastating diseases.
Releases published on the JNS Wire are communicated and paid for by third parties. Jewish News Syndicate, and any of its distribution partners, take zero responsibility for the accuracy of any content published in any press release. All the statements, opinions, figures in text or multimedia including photos or videos included in each release are presented solely by the sponsoring organization, and in no way reflect the views or recommendation of Jewish News Syndicate or any of its partners. If you believe any of the content in a release published on JNS Wire is offensive or abusive, please report a release.